07:00 , Sep 5, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Neurology Adenosine monophosphate deaminase 2 (AMPD2) In vitro and genetic studies identified a subset of patients with pontocerebellar hypoplasia (PCH) who could benefit from treatment...